je.st
news
US experts review heart attack risk of diabetes drug
2013-06-09 08:24:16| Biotech - Topix.net
GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.
Tags: review
heart
risk
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||